Yaqrit is Drug Discovery in United Kingdom that focus on Fatty Liver Disease business. Founded in 2001. They cover business area such as operator, end, advanced liver disease, technical expertise, clinical trial design, execution, its global collaborator network, severely ill patient, cirrhosis, acute-on-chronic Liver Failure, ACLF, Non-alcoholic Steatohepatitis, (nash, non-alcoholic Fatty Liver Disease, NAFLD, develop economy, clinical and commercial success.
2001
( 23 years old in 2024 )
Fatty Liver Disease
-
The Elms Courtyard Bromesberrow
Ledbury HR8 1RZ
England, United Kingdom
Private
operatorendadvanced liver diseasetechnical expertiseclinical trial designexecutionits global collaborator networkseverely ill patientcirrhosisacute-on-chronic Liver FailureACLFNon-alcoholic Steatohepatitis(nashnon-alcoholic Fatty Liver DiseaseNAFLDdevelop economyclinical and commercial success
* We use standard office opening hours in near Yaqrit's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Yaqrit is Drug Discovery business from United Kingdom that founded in 2001 (23 years old in 2024), Yaqrit business is focusing on Fatty Liver Disease.
Yaqrit headquarter office and corporate office address is located in The Elms Courtyard Bromesberrow Ledbury HR8 1RZ England, United Kingdom.
Yaqrit was founded in United Kingdom.
In 2024, Yaqrit is currently focus on Fatty Liver Disease sector.
Above is snippet of Google Trends for "Fatty Liver Disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Yaqrit, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
